C4 Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
C4 Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
  • C4 Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$24.7M, a 8.77% increase year-over-year.
  • C4 Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$105M, a 21.8% increase year-over-year.
  • C4 Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$132M, a 3.37% decline from 2022.
  • C4 Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$128M, a 52.8% decline from 2021.
  • C4 Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$83.9M, a 26.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$132M -$4.32M -3.37% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 -$128M -$44.3M -52.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$83.9M -$17.6M -26.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 -$66.3M -$32.2M -94.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 -$34.1M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.